|
ABIO | Oruka Therapeutics, Inc. |
|
|
ABIO | Oruka Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 3.43 |
| Leverage | 3.45% |
| Market Cap | $ 417.6m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -115.9m |
| Margin | 2924.07% |
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and markets genetically engineered therapies for cardiovascular disease. The company is headquartered in Westminster, Colorado.